Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

DOXYCYCLINE MONO 150 MG TABLET

doxycycline
$0.7507per EA

Strength

150 mg/1

Manufacturer

Strides Pharma Inc.

NDC

64380020801

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

DOXYCYCLINE

Approval Type

Generic (ANDA)

FDA Application

ANDA065070

On Market Since

9/19/2022

Pharmacological Classes

Tetracycline-class Drug
Tetracyclines

Price History

1W

0.0%

1M

-2.0%

3M

-14.7%

6M

-25.2%

1Y

-37.6%

3Y

N/A

5Y

N/A

All

-33.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

DOXYCYCLINE HYCLATE 20 MG TAB
Generic
42806036201•Epic Pharma LLC
$0.0937
per EA
DOXYCYCLINE HYCLATE 20 MG TAB
Generic
53489064701•Sun Pharmaceutical Industries Inc.
$0.0937
per EA
DOXYCYCLINE HYCLATE 20 MG TAB
Generic
62135062390•Chartwell RX LLC
$0.0937
per EA
DOXYCYCLINE HYCLATE 20 MG TAB
Generic
62332035231•Alembic Pharmaceuticals Inc.
$0.0937
per EA
DOXYCYCLINE HYCLATE 20 MG TAB
Generic
68047071401•Larken Laboratories, Inc.
$0.0937
per EA
DOXYCYCLINE HYCLATE 20 MG TAB
Generic
68047071460•Larken Laboratories, Inc.
$0.0937
per EA
DOXYCYCLINE HYCLATE 100 MG CAP
Generic
00143980305•Hikma Pharmaceuticals USA Inc.
$0.1152
per EA
DOXYCYCLINE HYCLATE 100 MG CAP
Generic
00143980350•Hikma Pharmaceuticals USA Inc.
$0.1152
per EA
DOXYCYCLINE HYCLATE 100 MG CAP
Generic
00904042804•Major Pharmaceuticals
$0.1152
per EA
DOXYCYCLINE HYCLATE 100 MG CAP
Generic
00904042806•Major Pharmaceuticals
$0.1152
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy